INTRODUCTION: The correlation between dehydroepiandrosterone sulfate (DHEAS) decline and age led to the hypothesis that DHEAS might be a marker of primary aging, though conflicting data from observational studies of mortality do not support this. We evaluated concurrent DHEAS and functional decline in a very old cohort to test if DHEAS change tracks with functional change during aging. METHODS: DHEAS and functional performance (gait speed, grip strength, Modified Mini-Mental State Examination [3MSE] score, and digit symbol substitution test [DSST] score) were measured in 1996-1997 and 2005-2006 in 989 participants in the Cardiovascular Health Study All Stars study (mean age 85.2 years in 2005-2006, 63.5% women and 16.5% African American). We used multivariable linear regression to test the association of DHEAS decline with functional decline. RESULTS: After adjustment, each standard deviation decrease in DHEAS was associated with greater declines in gait speed (0.12 m/s, p = .01), grip strength (0.09 kg, p = .03), 3MSE score (0.13 points, p < .001), and DSST score (0.14 points, p = .001) in women only. Additional adjustment for baseline DHEAS attenuated the association with grip strength but did not alter other estimates appreciably, and baseline DHEAS was unassociated with functional decline. CONCLUSIONS: In this cohort of very old individuals, DHEAS decline tracked with declines in gait speed, 3MSE score, and DSST score, but not grip strength, in women independent of baseline DHEAS level. DHEAS decline might be a marker for age-associated performance decline, but its relevance is specific to women.
INTRODUCTION: The correlation between dehydroepiandrosterone sulfate (DHEAS) decline and age led to the hypothesis that DHEAS might be a marker of primary aging, though conflicting data from observational studies of mortality do not support this. We evaluated concurrent DHEAS and functional decline in a very old cohort to test if DHEAS change tracks with functional change during aging. METHODS:DHEAS and functional performance (gait speed, grip strength, Modified Mini-Mental State Examination [3MSE] score, and digit symbol substitution test [DSST] score) were measured in 1996-1997 and 2005-2006 in 989 participants in the Cardiovascular Health Study All Stars study (mean age 85.2 years in 2005-2006, 63.5% women and 16.5% African American). We used multivariable linear regression to test the association of DHEAS decline with functional decline. RESULTS: After adjustment, each standard deviation decrease in DHEAS was associated with greater declines in gait speed (0.12 m/s, p = .01), grip strength (0.09 kg, p = .03), 3MSE score (0.13 points, p < .001), and DSST score (0.14 points, p = .001) in women only. Additional adjustment for baseline DHEAS attenuated the association with grip strength but did not alter other estimates appreciably, and baseline DHEAS was unassociated with functional decline. CONCLUSIONS: In this cohort of very old individuals, DHEAS decline tracked with declines in gait speed, 3MSE score, and DSST score, but not grip strength, in women independent of baseline DHEAS level. DHEAS decline might be a marker for age-associated performance decline, but its relevance is specific to women.
Authors: Caterina Rosano; Eleanor M Simonsick; Tamara B Harris; Steven B Kritchevsky; Jennifer Brach; Marjolein Visser; Kristine Yaffe; Anne B Newman Journal: Neuroepidemiology Date: 2005 Impact factor: 3.282
Authors: Anne R Cappola; Qian-Li Xue; Jeremy D Walston; Sean X Leng; Luigi Ferrucci; Jack Guralnik; Linda P Fried Journal: J Gerontol A Biol Sci Med Sci Date: 2006-09 Impact factor: 6.053
Authors: K G Sorwell; J Garten; L Renner; A Weiss; V T Garyfallou; S G Kohama; M Neuringer; H F Urbanski Journal: Rejuvenation Res Date: 2012-04 Impact factor: 4.663
Authors: Anne B Newman; Jason L Sanders; Jorge R Kizer; Robert M Boudreau; Michelle C Odden; Adina Zeki Al Hazzouri; Alice M Arnold Journal: Int J Epidemiol Date: 2016-06-06 Impact factor: 7.196
Authors: Jason L Sanders; Victoria Ding; Alice M Arnold; Robert C Kaplan; Anne R Cappola; Jorge R Kizer; Robert M Boudreau; Mary Cushman; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2013-06-28 Impact factor: 6.053
Authors: Guangju Zhai; Alexander Teumer; Lisette Stolk; John R B Perry; Liesbeth Vandenput; Andrea D Coviello; Annemarie Koster; Jordana T Bell; Shalender Bhasin; Joel Eriksson; Anna Eriksson; Florian Ernst; Luigi Ferrucci; Timothy M Frayling; Daniel Glass; Elin Grundberg; Robin Haring; Asa K Hedman; Albert Hofman; Douglas P Kiel; Heyo K Kroemer; Yongmei Liu; Kathryn L Lunetta; Marcello Maggio; Mattias Lorentzon; Massimo Mangino; David Melzer; Iva Miljkovic; Alexandra Nica; Brenda W J H Penninx; Ramachandran S Vasan; Fernando Rivadeneira; Kerrin S Small; Nicole Soranzo; André G Uitterlinden; Henry Völzke; Scott G Wilson; Li Xi; Wei Vivian Zhuang; Tamara B Harris; Joanne M Murabito; Claes Ohlsson; Anna Murray; Frank H de Jong; Tim D Spector; Henri Wallaschofski Journal: PLoS Genet Date: 2011-04-14 Impact factor: 5.917
Authors: Agnieszka Guligowska; Zuzanna Chrzastek; Marek Pawlikowski; Malgorzata Pigłowska; Hanna Pisarek; Katarzyna Winczyk; Tomasz Kostka Journal: Front Endocrinol (Lausanne) Date: 2021-12-24 Impact factor: 5.555